SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-235789
Filing Date
2009-11-16
Accepted
2009-11-16 16:28:14
Documents
9
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 386176
2 EIGHTH AMENDMENT TO LEASE AGREEMENT AND CONDITIONAL TERMINATION OF LEASE dex101.htm EX-10.1 27249
3 NINTH AMENDMENT TO AND CONTINUATION OF LEASE AGREEMENT dex102.htm EX-10.2 12395
4 NINTH AMENDMENT TO LEASE AGREEMENT AND CONDITIONAL TERMINATION OF LEASE dex103.htm EX-10.3 60056
5 ASSET PURCHASE AGREEMENT dex104.htm EX-10.4 226563
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6189
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6187
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3256
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3282
  Complete submission text file 0001193125-09-235789.txt   732789
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23930 | Film No.: 091187268
SIC: 2836 Biological Products, (No Diagnostic Substances)